Skip to main content

Plaintiffs Allege J&J Talc For Ovarian Cancer

Plaintiffs Allege J&J Talc For Ovarian Cancer

Plaintiffs Allege J&J Talc For Ovarian Cancer

Introduction

In a recent complaint filed by a couple, talcum powder has been alleged to cause ovarian cancer, which led to hysterectomy and multiple surgeries.

According to the lawsuit, the woman was diagnosed with ovarian cancer in August 2016, which was allegedly caused due to years of exposure to talcum powder products. She underwent pelvic lymphadenectomy, radical abdominal hysterectomy, and paraaortic lymph node biopsy, as well as a bilateral salpingo-oophorectomy, where both ovaries and fallopian tubes were removed.

Nearly 12,000 Johnson’s Baby Powder lawsuits and Shower-to-Shower lawsuits are pending in courts nationwide, claiming that the manufacturer failed to warn about the risks of using talcum powder. Last month, a California jury awarded $29 million to a woman with cancer who used J&J talc. In addition, last year a Missouri jury returned a landmark $4.7 billion verdict for 22 women diagnosed with ovarian cancer. Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J. overlooks J&J's talcum powder multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) in the District of New Jersey.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!